Rare Mad Cow Disease Group Triggers Neurological & Neuromuscular Degeneration
Human prion diseases are very rare, yet there exists the potential risk of spontaneous infection, as well as disease acquired due to certain human behavior patterns. Prion disease exposure may be associated with travel to regions where such diseases have occurred in the past, medical treatment/surgery with the risk of blood contamination, eating infected meat or even the handling of infected animals. The mad cow disease (bovine spongiform encephalopathy or BSE) is reported to be the cause of the human disease (variant Creutzfeldt-Jakob disease or vCJD); moreover, there are other animal prion diseases (such as chronic wasting disease among deer and elk) that may not have been eradicated totally. Such factors need to be considered when debating the importance of continued prion disease surveillance, and this article discusses these in detail.
Clinical Features
Currently known human prion diseases include sporadic, familial (inherited) and iatrogenic Creutzfeldt-Jacob disease (CJD), Gerstmann-Straussler-Scheinker disease (GSS), fatal familial insomnia (FFI) and variant CJD. Better known as transmissible spongiform encephalopathies (TSEs), brain pathology involves the conformational switch of the harmless cellular prion protein (PrP-c) to its harmful isoform PrP-sc that is partially protease-resistant and infectious (see Figure 1). Abnormal changes in the prion protein cause deterioration in certain brain areas, forming sponge-like holes and gaps (thus, the term spongiform encephalopathy). In CJD, this degeneration results in the progressive neurological and neuromuscular symptoms – rapid loss of intellectual abilities, impaired memory and judgment and distinct personality changes (dementia). Later stages of the disorder may be characterized by loss of physical and intellectual functions, coma, and increased susceptibility to repeated infections of the respiratory tract (such as pneumonia). In many cases, life-threatening complications tend to develop less than a year after the disorder becomes apparent.